3.連結財務諸表及び主な注記
(1)連結貸借対照表
|
|
|
|
|
|
|
|
|
|
|
|
(単位:千円)
|
|
|
|
|
|
|
|
|
|
|
|
前連結会計年度
(2025年9月30日)
|
当連結会計年度
(2026年9月30日)
|
|
資産の部
|
|
|
|
|
流動資産
|
|
|
|
|
|
現金及び預金
|
4,776,831
|
6,448,994
|
|
|
|
受取手形、売掛金及び契約資産
|
4,198,333
|
8,628,913
|
|
|
|
商品及び製品
|
20,842
|
670,229
|
|
|
|
原材料及び貯蔵品
|
2,214
|
5,790
|
|
|
|
前渡金
|
248,763
|
101,380
|
|
|
|
その他
|
54,129
|
175,861
|
|
|
|
貸倒引当金
|
△2,965
|
△892
|
|
|
|
流動資産合計
|
9,298,148
|
16,030,277
|
|
|
固定資産
|
|
|
|
|
|
有形固定資産
|
|
|
|
|
|
|
建物及び構築物
|
786,379
|
1,625,956
|
|
|
|
|
|
減価償却累計額
|
△563,018
|
△618,129
|
|
|
|
|
|
建物及び構築物(純額)
|
223,360
|
1,007,826
|
|
|
|
|
土地
|
139
|
744,199
|
|
|
|
|
その他
|
291,681
|
12,166,167
|
|
|
|
|
|
減価償却累計額
|
△241,971
|
△11,558,719
|
|
|
|
|
|
その他(純額)
|
49,709
|
607,448
|
|
|
|
|
有形固定資産合計
|
273,209
|
2,359,474
|
|
|
|
無形固定資産
|
|
|
|
|
|
|
のれん
|
-
|
1,234,839
|
|
|
|
|
顧客関連資産
|
-
|
1,062,398
|
|
|
|
|
その他
|
95,877
|
177,994
|
|
|
|
|
無形固定資産合計
|
95,877
|
2,475,232
|
|
|
|
投資その他の資産
|
|
|
|
|
|
|
投資有価証券
|
607,191
|
883,736
|
|
|
|
|
繰延税金資産
|
162,771
|
165,050
|
|
|
|
|
その他
|
432,203
|
817,196
|
|
|
|
|
投資その他の資産合計
|
1,202,166
|
1,865,983
|
|
|
|
固定資産合計
|
1,571,254
|
6,700,690
|
|
|
資産合計
|
10,869,403
|
22,730,967
|
|
|
|
|
|
|
|
|
|
|
|
|
(単位:千円)
|
|
|
|
|
|
|
|
|
|
|
|
前連結会計年度
(2025年9月30日)
|
当連結会計年度
(2026年9月30日)
|
|
負債の部
|
|
|
|
|
流動負債
|
|
|
|
|
|
電子記録債務
|
-
|
1,619,131
|
|
|
|
買掛金
|
3,470,752
|
7,187,113
|
|
|
|
短期借入金
|
-
|
30,000
|
|
|
|
1年内返済予定の長期借入金
|
-
|
500,000
|
|
|
|
未払法人税等
|
36,538
|
275,252
|
|
|
|
契約負債
|
281,747
|
126,458
|
|
|
|
賞与引当金
|
103,099
|
255,478
|
|
|
|
役員賞与引当金
|
10,800
|
21,600
|
|
|
|
その他
|
263,477
|
743,398
|
|
|
|
流動負債合計
|
4,166,415
|
10,758,432
|
|
|
固定負債
|
|
|
|
|
|
長期借入金
|
-
|
4,125,000
|
|
|
|
退職給付に係る負債
|
300,473
|
647,277
|
|
|
|
役員退職慰労引当金
|
496,039
|
527,522
|
|
|
|
繰延税金負債
|
-
|
369,019
|
|
|
|
その他
|
87,114
|
224,543
|
|
|
|
固定負債合計
|
883,627
|
5,893,363
|
|
|
負債合計
|
5,050,042
|
16,651,796
|
|
純資産の部
|
|
|
|
|
株主資本
|
|
|
|
|
|
資本金
|
545,975
|
545,975
|
|
|
|
資本剰余金
|
505,551
|
518,403
|
|
|
|
利益剰余金
|
4,508,263
|
4,736,679
|
|
|
|
自己株式
|
△166
|
△166
|
|
|
|
株主資本合計
|
5,559,623
|
5,800,892
|
|
|
その他の包括利益累計額
|
|
|
|
|
|
その他有価証券評価差額金
|
75,224
|
83,190
|
|
|
|
その他の包括利益累計額合計
|
75,224
|
83,190
|
|
|
非支配株主持分
|
184,511
|
195,089
|
|
|
純資産合計
|
5,819,360
|
6,079,171
|
|
負債純資産合計
|
10,869,403
|
22,730,967
|
E34455
76810
株式会社レオクラン
LEOCLAN Co.,Ltd.
通期第1号参考様式 [日本基準](連結)
Japan GAAP
true
cte
cte
2025-10-01
2026-09-30
FY
2026-09-30
2024-10-01
2025-09-30
2025-09-30
1
false
false
false
76810
2026-11-13
76810
2025-10-01
2026-09-30
76810
2025-10-01
2026-09-30
jppfs_cor:CapitalStockMember
76810
2025-10-01
2026-09-30
jppfs_cor:CapitalSurplusMember
76810
2025-10-01
2026-09-30
jppfs_cor:NonControllingInterestsMember
76810
2025-10-01
2026-09-30
jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember
76810
2025-10-01
2026-09-30
jpcrp_cor:ReconcilingItemsMember
76810
2025-10-01
2026-09-30
jpcrp_cor:ReportableSegmentsMember
76810
2025-10-01
2026-09-30
jppfs_cor:RetainedEarningsMember
76810
2025-10-01
2026-09-30
jppfs_cor:ShareholdersEquityMember
76810
2025-10-01
2026-09-30
jpcrp_cor:TotalOfReportableSegmentsAndOthersMember
76810
2025-10-01
2026-09-30
jppfs_cor:TreasuryStockMember
76810
2025-10-01
2026-09-30
tse-acedjpfr-76810:MinimallyInvasiveMedicalDeviceSalesBusinessReportableSegmentMemberReportableSegmentMember
76810
2025-10-01
2026-09-30
tse-acedjpfr-76810:RemoteImageDiagnosisServiceBusinessReportableSegmentMember
76810
2025-10-01
2026-09-30
tse-acedjpfr-76810:RentalBusinessReportableSegmentMemberReportableSegmentMember
76810
2025-10-01
2026-09-30
tse-acedjpfr-76810:TotalMedicalSolutionBusinessReportableSegmentMember
76810
2025-10-01
2026-09-30
jppfs_cor:ValuationAndTranslationAdjustmentsMember
76810
2025-10-01
2026-09-30
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
76810
2026-09-30
76810
2026-09-30
jppfs_cor:CapitalStockMember
76810
2026-09-30
jppfs_cor:CapitalSurplusMember
76810
2026-09-30
jppfs_cor:NonControllingInterestsMember
76810
2026-09-30
jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember
76810
2026-09-30
jpcrp_cor:ReconcilingItemsMember
76810
2026-09-30
jpcrp_cor:ReportableSegmentsMember
76810
2026-09-30
jppfs_cor:RetainedEarningsMember
76810
2026-09-30
jppfs_cor:ShareholdersEquityMember
76810
2026-09-30
jpcrp_cor:TotalOfReportableSegmentsAndOthersMember
76810
2026-09-30
jppfs_cor:TreasuryStockMember
76810
2026-09-30
tse-acedjpfr-76810:MinimallyInvasiveMedicalDeviceSalesBusinessReportableSegmentMemberReportableSegmentMember
76810
2026-09-30
tse-acedjpfr-76810:RemoteImageDiagnosisServiceBusinessReportableSegmentMember
76810
2026-09-30
tse-acedjpfr-76810:RentalBusinessReportableSegmentMemberReportableSegmentMember
76810
2026-09-30
tse-acedjpfr-76810:TotalMedicalSolutionBusinessReportableSegmentMember
76810
2026-09-30
jppfs_cor:ValuationAndTranslationAdjustmentsMember
76810
2026-09-30
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
76810
2024-10-01
2025-09-30
76810
2024-10-01
2025-09-30
jppfs_cor:CapitalStockMember
76810
2024-10-01
2025-09-30
jppfs_cor:CapitalSurplusMember
76810
2024-10-01
2025-09-30
jppfs_cor:NonControllingInterestsMember
76810
2024-10-01
2025-09-30
jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember
76810
2024-10-01
2025-09-30
jpcrp_cor:ReconcilingItemsMember
76810
2024-10-01
2025-09-30
jpcrp_cor:ReportableSegmentsMember
76810
2024-10-01
2025-09-30
jppfs_cor:RetainedEarningsMember
76810
2024-10-01
2025-09-30
jppfs_cor:ShareholdersEquityMember
76810
2024-10-01
2025-09-30
jpcrp_cor:TotalOfReportableSegmentsAndOthersMember
76810
2024-10-01
2025-09-30
jppfs_cor:TreasuryStockMember
76810
2024-10-01
2025-09-30
tse-acedjpfr-76810:RemoteImageDiagnosisServiceBusinessReportableSegmentMember
76810
2024-10-01
2025-09-30
tse-acedjpfr-76810:TotalMedicalSolutionBusinessReportableSegmentMember
76810
2024-10-01
2025-09-30
jppfs_cor:ValuationAndTranslationAdjustmentsMember
76810
2024-10-01
2025-09-30
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
76810
2025-09-30
76810
2025-09-30
jppfs_cor:CapitalStockMember
76810
2025-09-30
jppfs_cor:CapitalSurplusMember
76810
2025-09-30
jppfs_cor:NonControllingInterestsMember
76810
2025-09-30
jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember
76810
2025-09-30
jpcrp_cor:ReconcilingItemsMember
76810
2025-09-30
jpcrp_cor:ReportableSegmentsMember
76810
2025-09-30
jppfs_cor:RetainedEarningsMember
76810
2025-09-30
jppfs_cor:ShareholdersEquityMember
76810
2025-09-30
jpcrp_cor:TotalOfReportableSegmentsAndOthersMember
76810
2025-09-30
jppfs_cor:TreasuryStockMember
76810
2025-09-30
tse-acedjpfr-76810:RemoteImageDiagnosisServiceBusinessReportableSegmentMember
76810
2025-09-30
tse-acedjpfr-76810:TotalMedicalSolutionBusinessReportableSegmentMember
76810
2025-09-30
jppfs_cor:ValuationAndTranslationAdjustmentsMember
76810
2025-09-30
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
76810
2024-09-30
76810
2024-09-30
jppfs_cor:CapitalStockMember
76810
2024-09-30
jppfs_cor:CapitalSurplusMember
76810
2024-09-30
jppfs_cor:NonControllingInterestsMember
76810
2024-09-30
jppfs_cor:RetainedEarningsMember
76810
2024-09-30
jppfs_cor:ShareholdersEquityMember
76810
2024-09-30
jppfs_cor:TreasuryStockMember
76810
2024-09-30
jppfs_cor:ValuationAndTranslationAdjustmentsMember
76810
2024-09-30
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
iso4217:JPY
xbrli:pure